Pharmacists in General Practice

Pharmacists in general practice are expected to improve medication efficacy and reduce medication complications and adverse effects. In order for pharmacists in practice to be sustainable, practice revenue needs to be taken into consideration. In this short study, conducted during a period of considerable practice and societal upheaval due to a coronavirus outbreak, a pharmacist in practice was able to reduce the overall medication count (-0.52 per patient) and increase the billings (‘standard’ +0.86, ‘nursing’ +0.29, ‘case conference’ +0.04 and ‘medication review’ +0.09) of patients the pharmacist contacted. Additional revenue per patient contacted is estimated at $89.73.

Cervical screening and intensive telephone-based case-finding

Identifying eligible women who either have no recorded cervical screening or whose last recorded screening is very overdue (most recent result 45 months or older 'Pap' smear) for targeted telephone-based recall. Interpreters are used as required, and the particular potential benefit of telephone-based recall for women of refugee/asylum-seeker background is explored.